4D Molecular Corp - FDMT Bozor kapitallashuvining balans qiymatiga nisbati
4D Molecular Therapeutics (FDMT) narxlar grafigi innovatsion DNKga asoslangan dori vositalarini ishlab chiqayotgan kompaniyaning trayektoriyasini aks ettiradi. Biznes gen terapiyasi sohasidagi nufuzi va o'zining maxsus ishlanmalarining aniqligidan foydalanadi. Aktivlarning himoyasi AAV vektorlari uchun eksklyuziv patentlar orqali ta'minlangan bo'lib, ushbu ko'rsatkich 1.74 darajasida turibdi. FDA ning qat'iy nazoratiga qaramay, makulyar distrofiya davolashdagi muvaffaqiyat oftalmologik xizmatlarning ulkan bozoriga kirish imkonini beradi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_FDMT_-_4D-Molecular-Therapeutics_-_Capitalization-to-Book-Value-Ratio "FDMT: 4dmoleculartherapeutics.com Bozor qiymatining balans qiymatiga nisbati 04.07.2022 - 29.10.2026 | 👁️GURU.Markets👁️")
FDMT (4DMT): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati 4D Molecular Therapeutics|FDMT - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi 4D Molecular Therapeutics Inc|FDMT - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati 4D Molecular Therapeutics Inc|FDMT - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari 4D Molecular Therapeutics
Kompaniyaning asosiy tahlili:FDMT (4D Molecular Therapeutics)
4D Molecular Therapeutics (FDMT) kompaniyasining R&D jarayonlari uchun xomashyo zaxiralari moddiy bazani tashkil etadi va bozor uni kapitalizatsiyaning buxgalteriya qiymatiga nisbati ko'rsatilgan grafik orqali real aktivlarga nisbatan baholaydi. Ushbu koeffitsiyent kompaniyaning bozor qiymatini uning sof kapitaliga solishtiradi, bu esa investorlarga spekulyativ vasvasani aktivlarga bo'lgan fundamental ishonch va uzoq muddatli biznes barqarorligidan ajratish imkonini beradi.
Toʻgʻridan-toʻgʻri raqobatchilar
TEM (Tempus Labs) - Kapitallashuvning sof aktivlarga nisbati|QGEN: Bozor kapitallashuvining balans qiymatiga multiplikatori|IONS (Ionis) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati RGEN (Repligen Corp)|Bozor qiymatining balans qiymatiga nisbati Avidity (RNA)|CRISPR - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|Beam Therapeutics (BEAM) - Kapitallashuvning balans qiymatiga nisbati|SRPT - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Twist Bio|Kapitallashuvning sof aktivlarga nisbati 10x|NTLA - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati STOK|Kapitallashuvning sof aktivlarga nisbati BLFS (BioLife Solutions)|Bozor qiymatining balans qiymatiga nisbati WVE (Wave Life Sciences Ltd)|MAZE: Bozor qiymatining balans qiymatiga koeffitsiyenti|Sionna Corp - Bozor qiymatining balans qiymatiga nisbati|PRME - Bozor qiymatining balans qiymatiga nisbati|TSHA - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti QURE|MeiraGTx Holdings (MGTX) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati RGNX|Kapitallashuvning sof aktivlarga nisbati Solid Corp (SLDB)|Bozor kapitallashuvining balans qiymatiga nisbati OCGN|Bozor qiymatining balans qiymatiga nisbati PACB (pacb.com)|Bozor qiymatining balans qiymatiga nisbati Benitec Biopharma BNTC|Bozor kapitallashuvining balans qiymatiga nisbati Design Therapeutics Inc DSGN|Rocket Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|LXEO: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati korrobio.com KRRO|Kapitallashuvning sof aktivlarga nisbati editasmedicine.com|SLN - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati ProQR Therapeutics NV (PRQR)|Bozor kapitallashuvining balans qiymatiga multiplikatori Codexis, Inc.|Bozor kapitallashuvining balans qiymatiga nisbati Sangamo BioSciences (SGMO)|Balans qiymatiga nisbatan bozor qiymati Nautilus Bio|Bozor kapitallashuvining balans qiymatiga nisbati metagenomi.co MGX|DTIL (Precision BioSciences) - Bozor qiymatining balans qiymatiga koeffitsiyenti|GBIO: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Boundless Bio, Inc BOLD|Exicure (XCUR) - Bozor kapitallashuvining balans qiymatiga nisbati|IMNN (Imunon Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati PHIO|MBIO - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati transcodetherapeutics.com (RNAZ)|BNGO: Bozor qiymatining balans qiymatiga koeffitsiyenti|APDN - Kapitallashuvning sof aktivlarga nisbati|bluebird bio, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|ImmunoPrecise Antibodies (IPA) - Kapitallashuvning sof aktivlarga nisbati|OMGA - Bozor kapitallashuvining balans qiymatiga multiplikatori|Singular Genomics Systems, Inc. (OMIC) - Bozor kapitallashuvining balans qiymatiga nisbati|RGLS: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Syros Pharmaceuticals, Inc|Kapitallashuvning sof aktivlarga nisbati TBIO (Telesis Bio, Inc.)|Bozor qiymatining balans qiymatiga nisbati TCON (traconpharma.com)|Balans qiymatiga nisbatan bozor kapitallashuvi UBX